{"id":11246,"date":"2020-06-01T00:00:00","date_gmt":"2020-06-01T00:00:00","guid":{"rendered":"https:\/\/www.cancerresearch.org\/media-room\/eighth-annual-cancer-immunotherapy-month-in-june-celebrates-progress-in-treatment-and-advances-in-research\/"},"modified":"2022-07-13T04:10:26","modified_gmt":"2022-07-13T04:10:26","slug":"eighth-annual-cancer-immunotherapy-month-june","status":"publish","type":"cri_news","link":"https:\/\/www.cancerresearch.org\/es\/media-room\/eighth-annual-cancer-immunotherapy-month-june","title":{"rendered":"Eighth Annual Cancer Immunotherapy Month\u2122 in June Celebrates Progress in Treatment and Advances in Research"},"content":{"rendered":"\n

The Cancer Research Institute (CRI), a nonprofit organization dedicated since 1953 to saving more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer, announced today a series of public education and awareness offerings during its eighth annual Cancer Immunotherapy Month\u2122 in June. The multimedia campaign aims to reach more than 5 million people globally to increase awareness of cancer immunotherapy (also known as immuno-oncology), clinical trials, and the urgent need for more funding to support lifesaving immunotherapy research.<\/p>\n\n\n\n

\u201cDecades of scientific research on the immune system and its response to cancer have yielded a foundation for new treatments that can significantly extend or save lives for subsets of people with cancer who receive immunotherapy alone or in combination with other types of treatment,\u201d said Jill O\u2019Donnell-Tormey, PhD, CEO and director of scientific affairs at CRI. \u201cMore research is needed to extend the benefits of immunotherapy to all cancer patients, and our goal is to raise awareness of the critical role patients, caregivers, advocates, scientists, and donors who support their research play in advancing immuno-oncology breakthroughs.\u201d<\/p>\n\n\n\n

Over the past ten years, the FDA has approved immunotherapies to treat more than 20 types of cancer as well as cancers with a specific genetic mutation. This includes approvals for front-line therapy, where immunotherapy is given as the first course of treatment instead of conventional chemotherapy or radiation. Immunotherapy has also been shown to work synergistically with these and other treatments, offering more options for patients.<\/p>\n\n\n\n

Cancer Immunotherapy Month\u2122 aims to bring exciting advances like these into focus and to provide the public, including cancer patients and their caregivers, with trusted information to help them make the most informed treatment decisions in consultation with their medical team.<\/p>\n\n\n\n

Important highlights of Cancer Immunotherapy Month include:<\/p>\n\n\n\n

\u201cI\u2019m the Answer to Cancer\u201d Immunotherapy Patient Stories<\/strong>
Each week in June, CRI will feature video stories of patients<\/a> sharing their cancer immunotherapy journeys, from diagnosis to treatment to living beyond treatment. Featured cancer types include esophageal, kidney, lung, and oral cancer.<\/p>\n\n\n\n

Wear White for a Future Immune to Cancer<\/strong>
On Friday, June 12, CRI invites the world to Wear White for a Future #Immune2Cancer<\/a> to help raise awareness about the lifesaving potential of immunotherapy through the community-building power of social media. Getting involved is simple: wear white, snap and share a selfie on Twitter or Instagram, and use the hashtag #Immune2Cancer.<\/p>\n\n\n\n

Live Stream Event: COVID-19 and Cancer Immunotherapy Research<\/strong>
On Thursday, June 18, at 3pm EDT, CRI immunotherapy experts Drs. Carl June, Miriam Merad, and E. John Wherry will join STAT<\/em> news\u2019 senior medical writer, Matthew Herper, for a live stream event discussing how cancer immunotherapy research is aiding global efforts to treat COVID-19 patients and prevent future outbreaks. The discussion will be followed with a live Q&A session. Register at cancerresearch.org\/covid-19-livestream<\/a>.<\/p>\n\n\n\n

Live Webinar \u2013 Cancer Immunotherapy and You\u2122: Understanding Genomics and Genetic Testing<\/strong>
On Wednesday, June 24, at 12pm EDT, CRI will host a free, live webinar featuring Drs. Corrie Painter and Eliezer Van Allen of the Broad Institute of MIT and Harvard, who will discuss how genetic testing is helping inform cancer treatment decisions and how scientists are working to tap the full potential of genome-based medicine, followed by their answers to questions submitted by viewers. Register at cancerresearch.org\/webinars<\/a>.<\/p>\n\n\n\n

Other Awareness, Educational, and Fundraising Activities<\/strong>
Throughout June, CRI will also provide daily immunotherapy highlights from the ASCO and AACR virtual meetings<\/a>, share a series of 30 Outlooks<\/a> from CRI scientists, patient community members, and donors about their vision for the future of cancer treatment, and offer an interactive cancer immunotherapy quiz<\/a>. Cancer Immunotherapy Month activity will be shared across social media with the hashtag #CIM20. Finally, through June 30, all donations to CRI<\/a> up to the first $300,000 will be matched dollar-for-dollar, helping to fuel more discovery to save more lives.<\/p>\n\n\n\n

The Cancer Research Institute would like to thank the following generous sponsors of the eighth annual Cancer Immunotherapy Month:<\/p>\n\n\n\n